News and Trends 7 Dec 2022
ExPLoRNA Therapeutics receives mRNA technology funding
ExPLoRNA Therapeutics, a Polish biotech company working on mRNA vaccines and therapeutics, has received funding from the Bill & Melinda…
Poland
- Latest Posts
News and Trends 28 Nov 2022
Molecure to conduct cancer treatment trial in Poland
Molecure S.A. says the President of the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products has…
News and Trends 19 Sep 2022
Cyxone receives approval for phase 2b rheumatoid arthritis study
Swedish biotech company Cyxone has received approval from the Medical Product Agency (Office for Registration of Medicinal Products, Medical devices…
In Depth 7 Sep 2022
The biggest private biotech investments in August 2022
The healthcare-focused companies Orna Therapeutics, F2G and Sironax bagged the biggest biotech investments in August 2022, with mRNA vaccines, genomics…
ADVERTISEMENT
News and Trends 17 Aug 2022
Ryvu Therapeutics bags €22M from EIB to work on new cancer treatments
The European Investment Bank (EIB) is providing €22 million ($22.4 million) in financing to Ryvu Therapeutics, a Polish clinical-stage drug…
In Depth 3 Aug 2022
The biggest European biotech investments in July 2022
The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with runners-up including AgomAb and Tropic…
Best in Biotech 8 Jul 2022
10 Biotechnology companies leading the charge in Poland
These are the top 10 biotechnology companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot…
Startup Scout 19 Jul 2019
This Biotech Breaks Down ‘Undruggable’ Proteins to Treat Cancer
In the Polish city of Wrocław, Captor Therapeutics is developing cancer treatments that destroy disease-causing proteins. Mission: To develop cancer…
Startup Scout 31 May 2019
This Biotech Treats a Neurological Autoimmune Disorder Using DNA
We’re jumping into Poland this week. Pure Biologics is a biotech based in Wrocław developing DNA molecules that could treat…
In Depth 22 May 2018
Poland’s Emerging Biotech Sector: The Time Is Right for Startups
Poland might not be the first place you associate with biotech, but the country is becoming an emerging hotspot for…
ADVERTISEMENT
Startup Scout 9 Feb 2018
This Polish Biotech Uses AI to Help Others Speed Up Precision Medicine Development
Following on from BioNext's software last week, we're in Kraków to visit Ardigen. This biotech develops technology to help us…
News and Trends 29 Jul 2016
Polish Selvita’s Inflammation Research used to start new Biotech in Scotland
The new Biotech Nodthera will be based in Edinburgh and focus on the discovery and development of novel small molecule candidates to…
News and Trends 18 May 2016
Polish Bioinformatics company backs US movement into Microbiome Research
In Kraków, the Bioinformatics company Ardigen has now partnered up with a US based Microbiome startup, EpiBiome, which is looking for the answer to…
News and Trends 22 Mar 2016
5 Cool Biotechs in Eastern Europe
Eastern Europe is home to fascinating culture and rising economies, but how is the Biotech scene developing there? Here are…
News and Trends 22 Sep 2015
Selvita moves in: The biggest Polish biotech on the Boston Block
Welcome to the US! Polish Selvita has announced its new US HQ in Cambridge (MA), which they hope will better…
News and Trends 15 Sep 2015
Will bacteriophages solve the antibiotic resistance problem in the EU?
French Pherecydes Pharma has launched the first EU clinical bacteriophage phase I/II trial to fight hospital acquired infections (HAIs) in…
ADVERTISEMENT
News and Trends 8 Jun 2015
Biosimilars will land in Poland thanks to a European loan
Biosimilars will have their Polish guarantor. Polpharma, the largest Polish producer of medicines, is the first benefactor of a €45M…
News and Trends 23 Mar 2015
Life Sciences have a new big player: Joint Polish Investment Fund Management
Poland’s first Institutional Venture Capital Fund dedicated to Life Sciences announced today the first closing of its new venture capital…